A surge in U.S.-China transactions is drawing scrutiny in Washington, where some lawmakers are pushing to slow the pace of investment. on.wsj.com/4yjz5TC
on.wsj.comPharmaceutical Companies Push Trump Administration to Protect China DealsA surge in U.S.-China transactions is drawing scrutiny in Washington, where some lawmakers are pushing to slow the pace of investment.
3 reposts9 likes